Samus Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Boston MA United States (2011)

Organization Overview

First Clinical Trial
2011
NCT01269593
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Samus Therapeutics | Samus Therapeutics Consultant | Samus Therapeutics, Inc.